About miniPCR
miniPCR is a company based in Cambridge (United States) founded in 2013. miniPCR offers products and services including miniPCR® thermal cyclers, blueGel™ electrophoresis, miniPCR® APP, and Bandit™ Electrophoresis Kit. miniPCR operates in a competitive market with competitors including NeuMoDx, GenMark Diagnostics, Stilla Technologies, Biomeme and Silicon Biosystems, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amplyus Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of miniPCR
miniPCR offers a comprehensive portfolio of products and services, including miniPCR® thermal cyclers, blueGel™ electrophoresis, miniPCR® APP, and Bandit™ Electrophoresis Kit.
Devices for DNA amplification in research and education
System for visualizing DNA separation quickly
Application for controlling thermal cyclers remotely
Kits for electrophoresis experiments in classrooms
Funding Insights of miniPCR
Investors in miniPCR
miniPCR has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked |
Investor details for miniPCR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by miniPCR
Investment portfolio details for miniPCR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - miniPCR
Detailed financials for miniPCR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Minipcr Comparisons
Peer comparison for miniPCR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of miniPCR
miniPCR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, GenMark Diagnostics, Stilla Technologies, Biomeme and Silicon Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Digital PCR solutions for research are developed and analyzed.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Provider of point of care molecular diagnostics solutions
|
Detailed competitors of miniPCR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Minipcr
Complete news archive for miniPCR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about miniPCR
miniPCR was founded in 2013 and raised its 1st funding round 1 year after it was founded.
miniPCR is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Founded in 2013 in Cambridge, United States, the company focuses on biotechnology instruments. PCR thermal cyclers and electrophoresis systems are produced, with the miniPCR device designed as a portable thermal cycler programmable through a free app on smartphones, tablets, or PCs. Field operations are supported by its robust build. The blueGel system integrates electrophoresis and visualization functions for streamlined workflows.
miniPCR's top competitors include GenMark Diagnostics, Stilla Technologies and NeuMoDx.
miniPCR offers miniPCR® thermal cyclers, blueGel™ electrophoresis, miniPCR® APP, and Bandit™ Electrophoresis Kit.
miniPCR has 1 investor. Key investors include MassChallenge.